The self-assembly of non-ionic amphiphiles with hydroxylated oxanorbornane head-group was controlled using amino acid units as spacers between hydrophilic and lipophilic domains to get spherical supramolecular aggregates suitable for drug delivery applications.
Achiral amphiphiles with hydroxylated oxanorbornane headgroups showed specific morphological characteristics and hierarchical preferences depending upon the nature of lipophilic units. Detailed scanning electron microscopic (SEM) studies showed that twisted ribbonlike aggregates are characteristic of monoalkoxyaryl lipids with hydrocarbon chain length in the range C10-C13; these systems also had a preference toward lamellar arrangement. Asymmetric packing of these lipids is a unique occurrence and shows that the presence of molecular chirality is not an absolute requirement for curvature effects in their supramolecular assemblies. Aryl units in these systems were found to be important for the observed morphological preferences, which became evident from comparative studies involving simple long chain esters without this moiety. Single-crystal X-ray diffraction analysis of one of the lipids from the latter group gave finer details of strong and weak secondary interactions, which operate during their assembly process. Introduction of more than one alkyl chain on the aromatic ring caused a notable shift in the packing propensity toward columnar arrangement. Most of these cone-shaped molecules were found to give doughnut-shaped aggregates from acetone solution through the intermediary of fibrous structures, which was confirmed through SEM, transmission electron microscopic, and atomic force microscopic studies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.